Delivery Order SPE2DB20D2104-SPE2DB25FMCUM

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,675.71, is for the delivery of 4566874641 - Propranolol ER 80 mg capsules in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.82 firm fixed-price delivery order is for the supply of 100 capsules of Propranolol ER 80 mg, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of Propranolol ER 80 mg capsules. The contract has a firm fixed price of $13,919.16 and runs through January 27, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,194.98, is for the delivery of 100 capsules of 60 mg Propranolol ER (an extended-release cardiovascular medication). The contract has a completion date of February 26, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of 100 capsules of Propranolol ER 80 mg, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $5,034.33 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply 4,567,406,410 units of the drug Propranolol ER 80 mg capsules. The $3,503.57 firm fixed-price delivery order has a completion date of February 28, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,200.05 placed under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract. The contract is for the supply of 4,566,963,148 units of Propranolol ER 120 mg Capsule, a medication used to treat various cardiovascular conditions. The award has an ultimate completion date of January 17, 2025. The contract is not designated with a set-aside requirement, indicating...
This federal contract award, valued at $9,779.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Propranolol ER 80 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,799.94 firm fixed-price delivery order is for the supply of 100 counts of Propranolol ER 60 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,579.86, is for the delivery of 4566260744 - Propranolol ER 80 mg Capsule 100s, a cardiovascular medication. The award is a Delivery Order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMCUM
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Propranolol ER 80 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $2,414.60, is a firm-fixed-price delivery order with a completion date of November 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:23 PM